Please wait
F-4 F-4/A EX-FILING FEES 333-290954 0001129928 ONCOLYTICS BIOTECH INC N/A Y N 0001129928 2025-12-05 2025-12-05 0001129928 1 2025-12-05 2025-12-05 0001129928 1 2025-12-05 2025-12-05 0001129928 2 2025-12-05 2025-12-05 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

F-4

ONCOLYTICS BIOTECH INC

Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Stock, par value $0.001 per share 457(a) 150,000,000 $ 0.90 $ 135,000,000.00 0.0001381 $ 18,643.50
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 135,000,000.00

$ 18,643.50

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 17,067.41

Net Fee Due:

$ 1,576.09

Offering Note

1

Includes the shares into which all common shares, no par value, of Oncolytics Biotech Inc. ("Common Shares") that are issued and outstanding immediately prior to the Domestication (as defined in the management circular/prospectus) will be converted in the Domestication. Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Common Shares on The Nasdaq Stock Market, LLC on December 3, 2025, in accordance with Rule 457(f)(1).

Table 2: Fee Offset Claims and Sources ☐Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rules 457(b) and 0-11(a)(2)
Fee Offset Claims 1 F-4 333-290954 10/20/2025 $ 17,067.41
Fee Offset Sources Oncolytics Biotech Inc. F-4 333-290954 10/20/2025 $ 17,067.41
Rule 457(p)
Fee Offset Claims
Fee Offset Sources

Explanation of the basis for claimed offset:

1

There were 104,735,039 shares previously registered on the initial filing of this registration statement on Form F-4, filed on October 20, 2025 (File No. 333-290954), for which a registration fee of $17,067.41 was previously paid.

Table 3: Combined Prospectuses ☑Not Applicable

Security Type

Security Class Title

Amount of Securities Previously Registered

Maximum Aggregate Offering Price of Securities Previously Registered

Form Type

File Number

Initial Effective Date

N/A N/A N/A N/A N/A N/A N/A N/A